BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1060474)

  • 1. Chronic myelogenous leukemia presenting in the blastic phase and its association with a 45 XO Ph1 karyotype.
    Nigam R; Dosik H
    Blood; 1976 Feb; 47(2):223-7. PubMed ID: 1060474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomes and causation of human cancer and leukemia. XXI. Cytogenetically unusual cases of leukemia.
    Sonta S; Oshimura M; Sandberg AA
    Blood; 1976 Nov; 48(5):697-705. PubMed ID: 1067875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome abnormalities in chronic myeloid leukemia in children.
    Puchkova GP; Prigogina EL; Fleischmann EW; Drosdova TS; Mayakova SA; Peterson IS
    Hum Genet; 1983; 64(3):257-62. PubMed ID: 6576982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal changes in chronic granulocytic leukemia in blastic transformation and during remission.
    Beltran G; Varela M
    Cancer; 1980 Oct; 46(7):1590-3. PubMed ID: 6932255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Philadelphia-chromosome-negative chronic myelogenous leukemia with lymphoid stem cell blastic transformation.
    Kessler JF; Grogan TM; Greenberg BR
    Am J Hematol; 1985 Feb; 18(2):201-6. PubMed ID: 3855600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic myelogenous leukemia with a complex Ph1 translocation in an XYY male.
    Ohyashiki K; Oshimura M; Toyoda T; Sakai N; Ito H; Yamamoto K; Tonomura A
    Cancer Genet Cytogenet; 1984 Feb; 11(2):215-9. PubMed ID: 6607101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translocations (4p+; 6q-) and (12q-; Xp+) in blastic phase of a Ph1-positive chronic myeloid leukemia.
    Suciu S; Marinca E; Bornuz F; Crisan M; Petrov L; Rădulescu E
    Blut; 1984 Oct; 49(4):325-30. PubMed ID: 6593103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of cytogenetic findings of erythroid colonies derived from a Ph+ ALL patient: fundamental differences between Ph+ ALL and blastic phase CML.
    Abe R; Ishibashi T; Kimura H; Uchida T; Kariyone S
    Cancer Genet Cytogenet; 1985 Sep; 18(1):49-54. PubMed ID: 3861235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythroblastic transformation of Philadelphia chromosome (Ph1)-positive chronic myelogenous leukemia associated with marked chromosomal rearrangements.
    Sadamori N; Ikeda S; Muta T; Ichimaru M; Matsunaga M
    Cancer Genet Cytogenet; 1981 Jun; 3(4):353-7. PubMed ID: 6942912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-random karyotypic evolution in chronic myeloid leukemia.
    Mitelman F; Levan G; Nilsson PG; Brandt L
    Int J Cancer; 1976 Jul; 18(1):24-30. PubMed ID: 1065618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Philadelphia chromosome (Ph1)-negative chronic myelogenous leukemia (CML): a clonal disease with origin in a multipotent stem cell.
    Fialkow PJ; Jacobson RJ; Singer JW; Sacher RA; McGuffin RW; Neefe JR
    Blood; 1980 Jul; 56(1):70-3. PubMed ID: 6930309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different cell clones in bone marrow and spleen of a patient with chronic myelocytic leukemia (CML) in blastic phase.
    Olinici CD; Petrov L; Macavei I; Dobay O
    Cancer; 1978 Dec; 42(6):2707-9. PubMed ID: 282004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome changes and splenectomy in Ph1-positive chronic myeloid leukemia. I. Predictive parameters in the blastic phase.
    Sadamori N; Sandberg AA
    Cancer; 1984 Dec; 54(11):2456-9. PubMed ID: 6594187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations on karyotype evolution in patients with chronic myeloid leukemia (CML).
    Haas OA; Schwarzmeier JD; Nacheva E; Fischer P; Paietta E
    Blut; 1984 Jan; 48(1):33-43. PubMed ID: 6580930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clones with 3 Ph1 and 4 Ph1 in the terminal phase of three cases of chronic myeloid leukemia.
    Cabrol C; Peytremann R; Maurice PA
    Acta Haematol; 1982; 67(3):150-9. PubMed ID: 6805200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Philadelphia chromosome-negative chronic myelogenous leukemia with trisomy D.
    Shashaty GG; Baumiller RC
    Arch Pathol Lab Med; 1980 Jul; 104(7):376-8. PubMed ID: 6930938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomes and causation of human cancer and leukemia. XXV. Significance of the Ph1 (including unusual translocations) in various acute leukemias.
    Oshimura M; Sandberg AA
    Cancer; 1977 Sep; 40(3):1149-60. PubMed ID: 332321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic myelogenous leukemia. Association with 45 XO Philadelphia chromosome karyotype and prolonged survival.
    Waddell CC; Brown JA; Zelnick PW
    Arch Intern Med; 1980 Feb; 140(2):270-1. PubMed ID: 6928098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of cells with unmasked and masked Ph1 in a case of chronic myeloid leukemia in blastic phase.
    Pedersen B
    Cancer Genet Cytogenet; 1984 Jun; 12(2):129-37. PubMed ID: 6586280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chromosomes and causation of human cancer and leukemia: XXXVIII. Cytogenetic experience in Ph1-negative chronic myelocytic leukemia (CML).
    Kohno S; Abe S; Sandberg AA
    Am J Hematol; 1979; 7(3):281-91. PubMed ID: 296877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.